Crossmark

Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials

Published Online: 2024-05-11

Published Print: 2024-08

Authors

Kobayashi, Takaomi https://orcid.org/0000-0002-2319-5440
Morimoto, Tadatsugu

Ito, Koji

Mawatari, Masaaki

Shimazaki, Takafumi
License Information

Text and Data Mining valid from 2024-05-11

Version of Record valid from 2024-05-11
More Information

Article History

Received: 26 December 2023

Accepted: 3 May 2024

First Online: 11 May 2024

Declarations

:

: Takaomi Kobayashi, Tadatsugu Morimoto, Koji Ito, Masaaki Mawatari, and Takafumi Shimazaki declare that they have no conflict of interest.

Document is current